8th October 2003
Lawrence plc - ECO Animal Health Drug Registrations
In my Chairman's Statement in the Annual Report in July 2003, I
commented on the difficulty in forecasting the precise timing of the
grant of drug registrations. I am therefore delighted to announce that
our ECO Animal Health subsidiary has now received marketing
authorisations through the European Mutual Recognition Procedure for a
further ten important member states of the European Union. These
registrations are for Ecomectin injection for use against parasitic
infections in certain livestock.
This is the largest registration received by ECO Animal Health to date.
These new registrations represent an exciting and very significant
market opportunity for our drug, which is already selling well in a
number of international markets. We expect sales in Europe from these
new registrations to commence in the new year upon completion of the
necessary administrative arrangements. These new registrations will
contribute increasingly to the results for our financial year ending
March 2005 as sales develop.
We are expecting further important drug registrations over the coming
months and as always will keep shareholders advised of progress.
Contacts:
Peter Lawrence
Chairman, Lawrence plc
020 8336 2900
Anthony Spiro
Spiro Financial
020 8949 0428
Lawrence plc is a leader in the development, manufacture and
distribution of principally specialist chemical and pharmaceutical
products for the animal health, farming, fish and domestic pet markets
worldwide. Our products for these growth markets incorporate natural
ingredients to promote well-being and sustainability. We achieve our
financial goals through the careful and responsible application of
science to generate value for our shareholders.
Our recently launched new corporate web site www.lawrenceplc.com
includes our press releases together with general information about the
company and its subsidiaries. Each subsidiary also has a web site, which
gives further information about that business and its products.